AVTR
Get informed when a big investor buys or sells
+ FollowUndervalued by 33.5% based on the discounted cash flow analysis.
| Market cap | $9.78 Billion |
|---|---|
| Enterprise Value | $9.51 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.78 |
| Beta | 0.89 |
| Outstanding Shares | 676,200,000 |
| P/E Ratio | -17.24 |
|---|---|
| PEG | 41.93 |
| Price to Sales | - |
| Price to Book Ratio | 1.67 |
| Enterprise Value to Revenue | 1068.58 |
| Enterprise Value to EBIT | -36.08 |
| Enterprise Value to Net Income | -17 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.8398▼ 1825.80% |
|---|---|
| Total Calls | 440,000▼ 8.68% |
| Total Puts | 369,500▼ 95.98% |
Holdings and activity of institutional investors.
| Ownership % | 103.79%▲ 4.16% |
|---|---|
| Total Invested | $7.48B▲ 41.09% |
| Investors Holding | 460▲ 16.00% |
No data
Avantor®, a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries.